Which has grown faster, KROS or NAGE?

Over the past five years, KROS grew revenue faster — KROS at a 172.50% CAGR versus NAGE at 15.80%.

Is KROS or NAGE more profitable?

NAGE runs the higher net margin — KROS at -553.88% versus NAGE at 12.39%.

How have KROS and NAGE total returns compared?

Over the past 5 years, KROS delivered -21.98% and NAGE delivered -15.72% annualized total return. Past performance doesn't predict future results.

Keros Therapeutics, Inc. (KROS) vs Niagen Bioscience Inc (NAGE)

A side-by-side comparison of Keros Therapeutics, Inc. and Niagen Bioscience Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KROS

Keros Therapeutics, Inc.

$226M

$11.42HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT

NAGE

Niagen Bioscience Inc

$215M

$2.70HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT

Total return — KROS vs NAGE

growth of $100 · dividends reinvested · last 6y

KROS -42.6% (-8.8%/yr)NAGE -23.4% (-4.4%/yr)NAGE compounded faster over this window

KROS NAGE

KROS vs NAGE: by the numbers

•KROS is the larger company ($226M vs $215M market cap).
•NAGE is profitable (12.39% net margin) while KROS runs a net loss (-553.88%).
•KROS grew revenue faster over the past five years (172.50% vs 15.80% CAGR).

Metrics side by side

Valuation

Metric	KROS	NAGE
P/E ratio	N/A	14.48
Forward P/E	N/A	18.72
P/S ratio	15.08	1.67
P/B ratio	0.86	2.61
EV / EBITDA	N/A	14.43
FCF yield	N/A	2.64%

Profitability

Metric	KROS	NAGE
Gross margin	94.68%	64.24%
Operating margin	28.94%	6.67%
Net margin	-553.88%	12.39%
ROE	-31.70%	19.38%
ROIC	-36.49%	8.84%

Growth (annualized)

Metric	KROS	NAGE
Revenue CAGR (5Y)	172.50%	15.80%
Total return CAGR (5Y)	-21.98%	-15.72%

Frequently asked

Which has grown faster, KROS or NAGE?: Over the past five years, KROS grew revenue faster — KROS at a 172.50% CAGR versus NAGE at 15.80%.
Is KROS or NAGE more profitable?: NAGE runs the higher net margin — KROS at -553.88% versus NAGE at 12.39%.
How have KROS and NAGE total returns compared?: Over the past 5 years, KROS delivered -21.98% and NAGE delivered -15.72% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KROS analysis Full NAGE analysis Interactive comparison tool

Dig into the metrics

Niagen Bioscience P/E ratio Keros Therapeutics ROE Niagen Bioscience ROE Keros Therapeutics operating margin Niagen Bioscience operating margin Keros Therapeutics revenue growth Niagen Bioscience revenue growth Keros Therapeutics free cash flow Niagen Bioscience free cash flow

Keros Therapeutics & Niagen Bioscience appear in these rankings

Fastest Revenue Growth Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.